FDA Inspection 1194448 — SGS North America Inc.

SGS North America Inc. — FEI 1418028

The FDA completed an inspection of SGS North America Inc. on January 10, 2023 in Lincolnshire, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 10, 2023
Fiscal Year
2023
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Lincolnshire, IL (United States)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures